1. In Vivo
  2. >>Innovation

How The EHR And New Data Streams Are Influencing Clinical Practice

 
• By Mark Ratner

A plethora of clinical studies are showing that new types of data, often captured in the EHR, can help improve the correlation between treatments and outcomes and favorably affect patient care as well as enhance drug development.

IV1806_Data-Mining_1200x675.jpg
Mining EHR data to create a more complete picture of the patient • Source: Gayle Rembold Furbert

In many ways, the electronic health record (EHR) remains the central tool for capturing the plethora of new streams of data bubbling through health care. Phenotype measures, patient-reported outcomes (often acquired using digital technology), information on habits and environment, baseline genomic data, claims data and other information increasingly funneled into the EHR are adding to a more complete picture of the patient.

Pharma and hi-tech companies are taking notice: witness recent events such as Apple’s announced intention to make health records portable...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation

Astellas’s New Head Of Innovation Lab Sets Fresh Direction For External R&D

 
• By David Wild

Launched in April 2025, Astellas’s Innovation Lab unites fragmented research units under Morten Sogaard to pursue focused indications, a dual-track R&D strategy and tailored partnerships that balance innovation, risk and collaboration.

ResMed Taps Wearables And GLP-1 Trends To Expand Sleep Care

 
• By Marion Webb

Resmed’s CMO Carlos Nunez discusses the sleep giant’s continued push from medtech into healthtech and its efforts to fix what he calls a “broken pathway” to diagnosis and treatment for millions with undetected sleep apnea.

Podcast: The Potential Of AI In Developmental Cell Biology

 
• By David Wild

In this episode, In Vivo speaks with Micha Breakstone, co-founder and CEO of Somite.AI, and Samantha Dale Strasser, VP of strategy, to explore how their techbio is applying foundation models to human cell differentiation.

Pharmatech Funding: What Corporate VCs Actually Want

 
• By David Wild

Corporate venture arms can be powerful growth partners, but founders who don’t take time to understand them risk missing their greatest value.

More from In Vivo

Podcast: The Potential Of AI In Developmental Cell Biology

 
• By David Wild

In this episode, In Vivo speaks with Micha Breakstone, co-founder and CEO of Somite.AI, and Samantha Dale Strasser, VP of strategy, to explore how their techbio is applying foundation models to human cell differentiation.

A Year Of Firsts As Biosimilars Build Momentum In US

 
• By Dave Wallace

In a busy year for US biosimilars, 2025 saw more than a dozen approvals as multiple biologics faced competition for the first time – including Stelara. However, concerns persist over the lack of rivals in development for numerous brands coming off-patent, with a hope that regulatory streamlining can

Pharmatech Funding: What Corporate VCs Actually Want

 
• By David Wild

Corporate venture arms can be powerful growth partners, but founders who don’t take time to understand them risk missing their greatest value.